GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.550
-0.030 (-1.16%)
At close: Feb 27, 2026, 4:00 PM EST
2.470
-0.080 (-3.14%)
After-hours: Feb 27, 2026, 6:58 PM EST

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4272--
Market Cap Growth
-25.00%-66.25%326.73%---
Enterprise Value
-4-13-2--
Last Close Price
2.556.91394.3216674.51--
PB Ratio
0.210.421.846.70--
P/TBV Ratio
0.610.421.846.70--
Debt / Equity Ratio
0.010.010.030.05-0.41-0.74
Net Debt / Equity Ratio
-1.36-1.36-1.22-6.93-0.41-0.73
Net Debt / EBITDA Ratio
0.680.680.600.16-0.30-3.33
Net Debt / FCF Ratio
0.800.800.570.20-0.61-4.16
Quick Ratio
3.113.113.070.670.010.02
Current Ratio
3.253.253.431.090.160.02
Return on Equity (ROE)
-238.17%-238.17%-382.52%---
Return on Assets (ROA)
-103.93%-103.93%-118.39%-416.93%-465.68%-226.54%
Return on Capital Employed (ROCE)
-198.90%-198.90%-200.70%-4300.00%139.00%22.80%
Earnings Yield
-324.47%-478.65%-110.90%-751.78%--
FCF Yield
-276.51%-407.91%-116.36%-518.87%--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q